ASCO 2021: CheckMate 920 Update Confirms Benefit of Nivolumab Plus Ipilimumab in Advanced Renal Cell Carcinoma With Brain Metastases
Findings were consistent with CheckMate 214
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.